The Intrahepatic T Cell Compartment Does Not Normalize Years after Therapy-Induced Hepatitis C Virus Eradication

Journal of Infectious Diseases

Volumn 212, Issue 3, 2015, Pages 386-390

  Spaan, Michelle ^a   Claassen, Mark A A ^a   Hou, Jun ^a   Janssen, Harry L A ^a,b   De Knegt, Robert J ^a   Boonstra, Andre ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

gene expression; IL 10; intrahepatic; TGF ; Treg

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR ALPHA; PEGINTERFERON ALPHA; PEGYLATED INTERFERON ALFA 2A; RIBAVIRIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VIRUS ANTIGEN; ANTIVIRUS AGENT;

CD4+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION PROFILING; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE COUNT; MEMORY T LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; TGFB1 GENE; TGFBR1 GENE; VIRAL CLEARANCE; BLOOD; COHORT ANALYSIS; DISEASE ERADICATION; HEPACIVIRUS; HEPATITIS C, CHRONIC; IMMUNOLOGY; LIVER; PATHOLOGY; VIROLOGY;

ANTIVIRAL AGENTS; COHORT STUDIES; DISEASE ERADICATION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER; T-LYMPHOCYTES, REGULATORY;

EID: 84939560515     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv059     Document Type: Conference Paper

References (15)

1. Klenerman P, Thimme R. T cell responses in hepatitis C: The good, the bad and the unconventional. Gut 2012; 61:1226-34.
2. Spaan M, Boonstra A, Janssen HLA. Immunology of hepatitis C infection. Best Pract Res Clin Gastroenterol 2012; 26:1049-61.
3. Rehermann B. Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells. Nat Med 2013; 19:859-68.
4. Claassen MAA, de Knegt RJ, Turgut D, Groothuismink ZMA, Janssen HL, Boonstra A. Negative regulation of hepatitis C virus specific immunity is highly heterogeneous and modulated by pegylated interferonalpha/ ribavirin therapy. PLoS One 2012; 7:e49389.
5. Claassen MA, de Knegt RJ, Janssen HL, Boonstra A. Retention of CD4+ CD25+FoxP3+ regulatory T cells in the liver after therapy-induced hepatitis C virus eradication in humans. J Virol 2011; 85:5323-30.
6. Claassen MA, de Knegt RJ, Tilanus HW, Janssen HL, Boonstra A. Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis. J Hepatol 2010; 52:315-21.
7. Rosenblum MD, Gratz IK, Paw JS, Lee K, Marshak-Rothstein A, Abbas AK. Response to self antigen imprints regulatory memory in tissues. Nature 2011; 480:538-42.
8. Gratz IK, Campbell DJ. Organ-specific and memory treg cells: specificity, development, function, and maintenance. Front Immunol 2014; 5:333.
9. Hou J, van Oord G, Groothuismink ZM, et al. Gene expression profiling to predict and assess the consequences of therapy-induced virus eradication in chronic HCV. J Virol 2014; 88:12254-64.
10. Kaplan DE, Ikeda F, Li Y, et al. Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis. J Hepatol 2008; 48:903-13.
11. Nelson DR, Lauwers GY, Lau JY, Davis GL. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: A pilot trial of interferon nonresponders. Gastroenterology 2000; 118:655-60.
12. Li S, Vriend LE, Nasser IA, et al. Hepatitis C virus-specific T-cellderived transforming growth factor beta is associated with slow hepatic fibrogenesis. Hepatology 2012; 56:2094-105.
13. Sanchez Rodriguez R, Pauli ML, Neuhaus IM, et al. Memory regulatory T cells reside in human skin. J Clin Invest 2014; 124:1027-36.
14. Veerapu NS, Raghuraman S, Liang TJ, Heller T, Rehermann B. Sporadic reappearance of minute amounts of hepatitis C virus RNA after successful therapy stimulates cellular immune responses. Gastroenterology 2011; 140:676-85.
15. Callendret B, Eccleston HB, Hall S, et al. T cell immunity and HCV reinfection after cure of chronic hepatitis C with an interferon-free antiviral regimen. Hepatology 2014; 60:1531-40.